Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,315 | -4,097 | -1,786 | -1,853 | -2,834 |
| Depreciation Amortization | 144 | 59 | 19 | 396 | 729 |
| Income taxes - deferred | N/A | N/A | N/A | 19 | 1 |
| Accounts receivable | -49 | 474 | -34 | -145 | 81 |
| Accounts payable and accrued liabilities | 442 | -30 | 0 | 191 | -29 |
| Other Working Capital | -3,058 | 380 | -754 | 10 | 1,070 |
| Other Operating Activity | 1,159 | -116 | 624 | -10 | 825 |
| Operating Cash Flow | $-8,677 | $-3,330 | $-1,931 | $-1,391 | $-158 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,081 | N/A | N/A | -96 | N/A |
| PPE Investments | -4,389 | -15 | -136 | -146 | -122 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 16 |
| Sale Of Investment | N/A | N/A | N/A | N/A | -76 |
| Purchase Sale Intangibles | -77 | -45 | -65 | 0 | N/A |
| Other Investing Activity | -77 | -245 | -521 | 0 | -1 |
| Investing Cash Flow | $-9,547 | $-260 | $-657 | $-241 | $-183 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 679 | 121 |
| Debt Repayment | N/A | -1,878 | 35 | -476 | 399 |
| Common Stock Issued | -59 | 29,458 | 3,489 | 642 | 1,744 |
| Other Financing Activity | 0 | 18 | 191 | -137 | -1,253 |
| Financing Cash Flow | $-59 | $27,598 | $3,715 | $708 | $1,011 |
| Exchange Rate Effect | -69 | -56 | -7 | -28 | -4 |
| Beginning Cash Position | 25,610 | 1,658 | 538 | 1,491 | 825 |
| End Cash Position | 7,258 | 25,610 | 1,658 | 538 | 1,491 |
| Net Cash Flow | $-18,352 | $23,952 | $1,120 | $-953 | $666 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,677 | -3,330 | -1,931 | -1,391 | -158 |
| Capital Expenditure | -4,389 | -15 | -136 | -146 | -122 |
| Free Cash Flow | -13,066 | -3,345 | -2,067 | -1,537 | -280 |